Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling
05:43

Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling

Published on: April 19, 2024

1.6K

Predictors of Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation

Miki Yokokawa1, Hakan Oral1, Aman Chugh1

  • 1Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan,USA.

Journal of Atrial Fibrillation
|May 13, 2017
PubMed

Insights

Pulmonary vein isolation is standard for paroxysmal atrial fibrillation (AF). For persistent AF, catheter ablation success is limited by high recurrence rates of atrial tachyarrhythmias, with predictors needing further investigation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Radiofrequency catheter ablation targeting pulmonary veins is a primary treatment for drug-refractory, paroxysmal atrial fibrillation.
  • The optimal ablation strategy for persistent atrial fibrillation remains unclear.
  • High rates of recurrent atrial tachyarrhythmias persist after ablation for persistent AF.

Purpose of the Study:

  • To review the predictors of recurrent atrial tachyarrhythmias after catheter ablation in patients with persistent atrial fibrillation.

Main Methods:

  • Literature review of studies investigating catheter ablation for persistent atrial fibrillation.
  • Analysis of factors associated with recurrence of atrial tachyarrhythmias post-ablation.

Main Results:

  • Predictors of recurrence in persistent AF ablation are multifactorial.
  • Understanding these predictors is crucial for improving ablation outcomes.

Conclusions:

  • Further research is needed to refine ablation strategies for persistent AF.
  • Identifying predictors can guide patient selection and procedural optimization to reduce recurrence.

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K
Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
716
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
547